Figure 14.
Scintigraphic scans from one individual showing the deposition of radiolabeled (99mTc) aerosol in the lungs immediately after administration of a single dose of 250 μg flunisolide delivered via the Respimat® SMI, pressurized metered dose inhaler, or pressurized metered dose inhaler plus spacer, on each of three study days.
Abbreviations: SMI, Soft Mist™ Inhaler; MDI, pressurized metered dose inhaler.
Note: Reprinted from International Journal of Pharmaceutics, Vol 283, Issue 1–2, R Dalby, M Spallek, T Voshaar, A review of the development of Respimat® Soft Mist™ Inhaler, Pages 1–9, Copyright 2004, with permission from Elsevier.